113 related articles for article (PubMed ID: 15833578)
1. Mecamylamine moderates cue-induced emotional responses in smokers.
McClernon FJ; Rose JE
Addict Behav; 2005 May; 30(4):741-53. PubMed ID: 15833578
[TBL] [Abstract][Full Text] [Related]
2. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.
Rose JE; Behm FM
Nicotine Tob Res; 2004 Jun; 6(3):523-32. PubMed ID: 15203786
[TBL] [Abstract][Full Text] [Related]
3. Precessation treatment with nicotine skin patch facilitates smoking cessation.
Rose JE; Behm FM; Westman EC; Kukovich P
Nicotine Tob Res; 2006 Feb; 8(1):89-101. PubMed ID: 16497603
[TBL] [Abstract][Full Text] [Related]
4. Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist.
Fonder MA; Sacco KA; Termine A; Boland BS; Seyal AA; Dudas MM; Vessicchio JC; George TP
Biol Psychiatry; 2005 Apr; 57(7):802-8. PubMed ID: 15820238
[TBL] [Abstract][Full Text] [Related]
5. A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects.
Reid MS; Mickalian JD; Delucchi KL; Berger SP
Neuropsychopharmacology; 1999 Mar; 20(3):297-307. PubMed ID: 10063490
[TBL] [Abstract][Full Text] [Related]
6. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
7. Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers.
Morissette SB; Palfai TP; Gulliver SB; Spiegel DA; Barlow DH
Psychol Addict Behav; 2005 Jun; 19(2):192-8. PubMed ID: 16011390
[TBL] [Abstract][Full Text] [Related]
8. Effects of d-amphetamine and smoking abstinence on cue-induced cigarette craving.
Alsene KM; Mahler SV; de Wit H
Exp Clin Psychopharmacol; 2005 Aug; 13(3):209-18. PubMed ID: 16173884
[TBL] [Abstract][Full Text] [Related]
9. A psychometric evaluation of cigarette stimuli used in a cue reactivity study.
Carter BL; Robinson JD; Lam CY; Wetter DW; Tsan JY; Day SX; Cinciripini PM
Nicotine Tob Res; 2006 Jun; 8(3):361-9. PubMed ID: 16801294
[TBL] [Abstract][Full Text] [Related]
10. Mecamylamine does not precipitate withdrawal in cigarette smokers.
Eissenberg T; Griffiths RR; Stitzer ML
Psychopharmacology (Berl); 1996 Oct; 127(4):328-36. PubMed ID: 8923568
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
Rose JE; Behm FM; Westman EC
Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
[TBL] [Abstract][Full Text] [Related]
12. Placebo cigarettes in a spaced smoking paradigm.
Eid NC; Fant RV; Moolchan ET; Pickworth WB
Pharmacol Biochem Behav; 2005 May; 81(1):158-64. PubMed ID: 15894074
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological interactions between nicotine and ethanol.
Rose JE; Brauer LH; Behm FM; Cramblett M; Calkins K; Lawhon D
Nicotine Tob Res; 2004 Feb; 6(1):133-44. PubMed ID: 14982697
[TBL] [Abstract][Full Text] [Related]
14. Changes in craving for a cigarette and arterial nicotine plasma concentrations in abstinent smokers.
Guthrie SK; Ni L; Zubieta JK; Teter CJ; Domino EF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):617-23. PubMed ID: 15276686
[TBL] [Abstract][Full Text] [Related]
15. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
[TBL] [Abstract][Full Text] [Related]
16. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.
McKee SA; Weinberger AH; Harrison EL; Coppola S; George TP
Schizophr Res; 2009 Dec; 115(2-3):317-24. PubMed ID: 19700263
[TBL] [Abstract][Full Text] [Related]
17. EEG correlates of imagery-induced cigarette craving in male and female smokers.
Knott V; Cosgrove M; Villeneuve C; Fisher D; Millar A; McIntosh J
Addict Behav; 2008 Apr; 33(4):616-21. PubMed ID: 18077100
[TBL] [Abstract][Full Text] [Related]
18. Effect of impulsivity on cardiovascular and subjective reactivity to smoking cues.
Doran N; McChargue D; Spring B
Addict Behav; 2008 Jan; 33(1):167-72. PubMed ID: 17566665
[TBL] [Abstract][Full Text] [Related]
19. Mecamylamine (Inversine): an old antihypertensive with new research directions.
Shytle RD; Penny E; Silver AA; Goldman J; Sanberg PR
J Hum Hypertens; 2002 Jul; 16(7):453-7. PubMed ID: 12080428
[TBL] [Abstract][Full Text] [Related]
20. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
